Market open
$
67.46
Change
+0.56 +0.84%
Volume
Volume 4.15m
Nov 30, 2023, 12:33 p.m.
Real time quotes
Previous close
$ 66.90
$ 67.46
Change
+0.56 +0.84%
Day low
Day high
$66.71
$67.87

52 week low
52 week high
$64.41
$104.83

Market cap
$86.09B
Average volume
6.69M
P/E ratio
10.19
Rev. per Employee
$1.16M
EPS
6.63
Dividend
0.61
Div yield
3.58%
Ex dividend date
10/19/23
MarketWatch News on CVS
-
Cigna’s and Humana’s stock slides on report of deal talks
- Eleanor Laise
-
Cigna and Humana Are in Merger Talks: WSJ. Why a Deal Might Make Sense.
- Josh Nathan-Kazis
-
Eye-drop maker recalls CVS, Target, Walmart-branded products
- Eleanor Laise
-
Amazon gets FDA warning on sale of unapproved eye drops
- Eleanor Laise
-
Amazon offers Prime members primary care for $9 a month
- Eleanor Laise
-
CVS Health now sees full-year EPS $6.37 to $6.61 vs. $6.53 to $6.75 previously
- Ciara Linnane
-
CVS Health Q3 adj. EPS $2.21; FactSet consensus $2.13
- Ciara Linnane
-
CVS Health Q3 revenue $89.8 bln; FactSet consensus $88.287 bln
- Ciara Linnane
- Loading more headlines...
Analyst Ratings
-
Is Walgreens Stock an Attractive Bet?
- MarketRealist.com
-
Analysts Aren’t So Sure about Rite Aid Stock
- MarketRealist.com
-
Wall Street Remains Positive on Walgreens
- MarketRealist.com
Other News on CVS
-
Cigna, Humana in Talks for Blockbuster Merger
- Lauren Thomas
-
Foot Locker, Teamsters Show Their Drug-Benefit Managers the Door
- Melanie Evans
-
Why Your Neighborhood Pharmacy Isn’t So Friendly Anymore
- Joseph Walker
-
Fed Pause Helps Treasury Yields Retreat and Stocks Climb
- David Uberti
-
If Some Cold Medicines Don’t Work, What Should You Take for a Stuffy Nose?
- Jared S. Hopkins
-
These Are the Two Scientists Taking Down Cold Medicines That Don’t Work
- Nidhi Subbaraman
-
CVS Pulls Certain Cold Medicines From Shelves and Will Stop Selling Them
- Jared S. Hopkins
-
Ozempic Boom Is an Opportunity for Health Insurers
- David Wainer
-
Rite Aid Files for Bankruptcy, Undone by Years of Losses
- Sarah Nassauer
-
New Walgreens CEO Needs to Cut the Dividend
- David Wainer
-
Home Depot Tracked a Crime Ring and Found an Unusual Suspect
- Inti Pacheco
-
This Out-of-Favor Sector Is Benefiting From Higher Rates
- David Wainer
-
Walgreens Test of Ad-Enabled Cooler Doors Ends Up in Court
- Katie Deighton
-
Covid Boosters Aren’t Reaching People Who Want Them
- Brianna Abbott
-
Uncle Sam Wants You—to Fight High Drug Prices
- Joseph Walker
-
Insurers Are Charging Thousands of Dollars for Generic Drugs
- Joseph Walker
- Loading more headlines...
Press Releases on CVS
-
CVS Health completes acquisition of Oak Street Health
- PR Newswire - PRF
-
CVS Health study spotlights rising mental health concerns
- PR Newswire - PRF
-
CVS Health completes rollout of time delay safes in Florida
- PR Newswire - PRF
-
CVS Health names Brian Kane President of Aetna
- PR Newswire - PRF
-
CVS Health to hold first quarter 2023 earnings conference call
- PR Newswire - PRF
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com